Disclosed herein is a pharmaceutical composition for skin that is a preparation containing a vitamin D3 compound and a corticosteroid as active ingredients, that is excellent in the stability of each of the active ingredients, and that has appropriate transdermal absorbability of the active ingredients. The composition is a non-aqueous composition for skin comprising: (a) maxacalcitol (b) at least one corticosteroid selected from the group consisting of betamethasone and esters thereof (c) at least one low-polarity ester oil having an IOB value of 0.07 or more but less than 0.20 and (d) at least one non-polar liquid solvent.
